Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 2 (FTH1P2) is a processed pseudogene related to the functional ferritin heavy chain 1 (FTH1) gene, a key element of cellular iron storage and antioxidant defense. Though FTH1P2 does not encode a protein, recent research indicates that it may have a functional regulatory role in gene expression by serving as a ceRNA (competing endogenous RNA), affecting the cellular levels of FTH1 and other related molecules by sponging microRNAs in cancer cell models. The ferritin gene family is characterized by its complexity, including several pseudogenes such as FTH1P2, which participate in intricate post-transcriptional regulatory networks and may influence cancer development and iron metabolism in specific tissues. FTH1P2 is distinguishable from the functional FTH1 gene, which encodes the iron storage protein ferritin heavy chain and is involved in iron metabolism and antioxidant defense. FTH1P2 is annotated as a processed pseudogene, meaning it is a non-coding genomic remnant derived from FTH1 by retrotransposition and does not encode a functional protein. Pseudogenes like FTH1P2 can exert biological functions by modulating parental gene activity through ceRNA interactions, notably by “sponging” miRNAs that would otherwise target FTH1 itself—this has been shown in prostate cancer models. There is no evidence that FTH1P2 is a direct therapeutic target for small molecules, antibodies, or other drugs, as it does not produce a protein or serve as a receptor, enzyme, transporter, or transcription factor. The major disease role for FTH1P2 is as a regulatory molecule in cancers, with emphasis in prostate cancer, through indirect modulation of iron metabolism. No known drugs are listed to directly interact with FTH1P2, nor are there established mechanisms of action or safety concerns for intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 2 (FTH1P2).